The U.S. House of Representatives Ways and Means Committee has solicited ASCO’s feedback and input on strategies to overhaul the Medicare reimbursement system. In a letter responding to the Committee’s request, ASCO underscores the need for a more rational, functional, and sustainable system of payment that incentivizes quality patient care.
ASCO has provided national leadership and expertise in cancer quality measure development, specification and testing through its Quality Oncology Practice Initiative (QOPI). In its response to the committee, the Society emphasizes the importance of oncologist-led quality improvement efforts such as QOPI, and encourages CMS to leverage ASCO’s existing programs as part of payment reform efforts.
Read the full story: http://hcp.lv/KgaVAO
Source: ASCO in Action
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More